Centro Cardiologico Universitario and LTTA Centre, University of Ferrara, Ferrara, Italy.
Noninvasive Cardiology Unit, Azienda Ospedaliero-Universitaria, Via Aldo Moro 8, 44124, Ferrara, Cona, Italy.
Heart Fail Rev. 2017 Nov;22(6):699-722. doi: 10.1007/s10741-017-9636-1.
Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart failure and left ventricular systolic dysfunction. Patients are usually assessed by echocardiography, which provides a number of anatomical and functional information used for cardiac dyssynchrony assessment, prognostic stratification, identification of the optimal site of pacing in the left ventricle, optimization of the CRT device, and patient follow-up. Compared to other cardiac imaging techniques, echocardiography has the advantage to be non-invasive, repeatable, and safe, without exposure to ionizing radiation or nefrotoxic contrast. In this article, we review current evidence about the role of echocardiography before, during, and after the implantation of a CRT device.
心脏再同步治疗(CRT)是心力衰竭和左心室收缩功能障碍患者的既定治疗方法。患者通常通过超声心动图进行评估,超声心动图提供了许多解剖和功能信息,用于评估心脏不同步、预后分层、确定左心室起搏的最佳部位、优化 CRT 设备以及患者随访。与其他心脏成像技术相比,超声心动图具有无创、可重复和安全的优势,不会接触到电离辐射或肾毒性对比剂。本文综述了在 CRT 设备植入前、植入中和植入后的超声心动图的作用的现有证据。